HomeLSL • CVE
add
LSL Pharma Group Inc
Previous close
$0.34
Day range
$0.33 - $0.33
Year range
$0.31 - $0.55
Market cap
38.13M CAD
Avg Volume
52.05K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.01M | 59.66% |
Operating expense | 1.11M | 54.32% |
Net income | -386.00K | 49.34% |
Net profit margin | -9.63 | 68.27% |
Earnings per share | — | — |
EBITDA | 440.00K | 363.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 164.00K | — |
Total assets | 37.96M | 28.00% |
Total liabilities | 17.59M | -11.63% |
Total equity | 20.37M | — |
Shares outstanding | 115.53M | — |
Price to book | 1.89 | — |
Return on assets | 0.57% | — |
Return on capital | 0.64% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -386.00K | 49.34% |
Cash from operations | -87.00K | 96.42% |
Cash from investing | -1.39M | -560.19% |
Cash from financing | 1.36M | -35.26% |
Net change in cash | -125.00K | 77.06% |
Free cash flow | -1.58M | 30.14% |
About
Founded
2010
Website
Employees
114
